Objective: Nebulized beta agonist, nebulized steroid and systemic steroids are being used in acute bronchiolitis treatment, but there is no consensus on the efficiacy of this regimen. In this study, comparison of clinical efficacies of these agents with uncertain outcomes was planned
Arformoterol, a long-acting beta-2 agonist, has a rapid onset and long duration of action. Its role ...
Background: There is no standard treatment option in acute bronchiolitis. 3-7% hypertonic saline (HS...
OBJECTIVE: To critically evaluate the following issues regarding the use of beta-agonists in the tre...
Objective: Nebulized beta agonist, nebulized steroid and systemic steroids are being used in acute b...
Acute bronchiolitis is a common, potentially life-threatening condition with few therapeutic options...
Background: Acute bronchiolitis is the most common form of lower respiratory tract infection in inf...
Objective: To decide the viability of steroids within the treatment of bronchiolitis. Patients and...
Objective: An appropriate treatment of acute viral bronchiolitis can reduce the symptoms, hospitaliz...
The aim of this paper is to compare the effect of nebulized magnesium sulfate to nebulized salbutamo...
BACKGROUND : Acute bronchiolitis is the most common condition in children with rapid respiration, c...
Background: A wide range of drugs are commonly used to treat bronchiolitis, but evidence of their ef...
Nebulized epinephrine decreases oxygen requirements, respiratory rate, wheezing, and retractions and...
Background: Bronchiolitis is a frequent cause of hospitalization. Despite the frequency of this path...
A prospective, open labelled, controlled trial was conducted in tertiary care centre, using standard...
Background. The morbidity from obstructive airways disease (asthma and chronic obstructive pulmonary...
Arformoterol, a long-acting beta-2 agonist, has a rapid onset and long duration of action. Its role ...
Background: There is no standard treatment option in acute bronchiolitis. 3-7% hypertonic saline (HS...
OBJECTIVE: To critically evaluate the following issues regarding the use of beta-agonists in the tre...
Objective: Nebulized beta agonist, nebulized steroid and systemic steroids are being used in acute b...
Acute bronchiolitis is a common, potentially life-threatening condition with few therapeutic options...
Background: Acute bronchiolitis is the most common form of lower respiratory tract infection in inf...
Objective: To decide the viability of steroids within the treatment of bronchiolitis. Patients and...
Objective: An appropriate treatment of acute viral bronchiolitis can reduce the symptoms, hospitaliz...
The aim of this paper is to compare the effect of nebulized magnesium sulfate to nebulized salbutamo...
BACKGROUND : Acute bronchiolitis is the most common condition in children with rapid respiration, c...
Background: A wide range of drugs are commonly used to treat bronchiolitis, but evidence of their ef...
Nebulized epinephrine decreases oxygen requirements, respiratory rate, wheezing, and retractions and...
Background: Bronchiolitis is a frequent cause of hospitalization. Despite the frequency of this path...
A prospective, open labelled, controlled trial was conducted in tertiary care centre, using standard...
Background. The morbidity from obstructive airways disease (asthma and chronic obstructive pulmonary...
Arformoterol, a long-acting beta-2 agonist, has a rapid onset and long duration of action. Its role ...
Background: There is no standard treatment option in acute bronchiolitis. 3-7% hypertonic saline (HS...
OBJECTIVE: To critically evaluate the following issues regarding the use of beta-agonists in the tre...